Jiangsu State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.
Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
J Med Chem. 2024 Sep 12;67(17):15080-15097. doi: 10.1021/acs.jmedchem.4c00722. Epub 2024 Aug 15.
The activation of PP5 is essential for a variety of cellular processes, as it participates in a variety of biological pathways by dephosphorylating substrates. However, activation of PP5 by small molecules has been a challenge due to its native "self-inhibition" mechanism, which is controlled by the N-terminal TPR domain and the C-terminal αJ helix. Here, we reported the discovery of , a well-identified TPR-independent PP5 allosteric activator, which facilitates the dephosphorylation process of downstream substrates. Considering the negative regulatory effect of PP5 on heat shock transcription factor HSF1, pharmacologic activation of PP5 by was found to reduce the HSP90 inhibitor-induced heat shock response. These results provide a chemical tool to advance the exploration of PP5 as a potential therapeutic target and highlight the value of pharmacological activation of PP5 to reduce heat shock toxicity of HSP90 inhibitors.
PP5 的激活对于各种细胞过程至关重要,因为它通过去磷酸化底物参与各种生物途径。然而,由于其天然的“自我抑制”机制,小分子激活 PP5 一直是一个挑战,该机制受 N 端 TPR 结构域和 C 端 αJ 螺旋的控制。在这里,我们报告了一种新型的 TPR 非依赖性 PP5 别构激活剂的发现,它促进了下游底物的去磷酸化过程。鉴于 PP5 对热休克转录因子 HSF1 的负调控作用,我们发现通过 对 PP5 的药理学激活可降低 HSP90 抑制剂诱导的热休克反应。这些结果提供了一种化学工具,可推进将 PP5 作为潜在治疗靶标的探索,并强调了药理学激活 PP5 以降低 HSP90 抑制剂的热休克毒性的价值。